A multinational phase IIb study to investigate the efficacy and safety of subcutaneous immunotherapy with a modified fish-parvalbumin given in single rising and maintenance doses to subjects allergic to fish.
Ficha Técnica
Investigador Principal
CARMEN MORENO AGUILAR
Promotor
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM